Richard Bonnet Selected Research

colibactin

1/2024	Colibactin-producing Escherichia coli enhance resistance to chemotherapeutic drugs by promoting epithelial to mesenchymal transition and cancer stem cell emergence.
1/2024	The colibactin-producing Escherichia coli alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistance.
1/2023	Cytotoxic necrotizing factor 1 hinders colon tumorigenesis induced by colibactin-producing Escherichia coli in ApcMin/+ mice.
1/2020	Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli.
1/2020	Autophagy of Intestinal Epithelial Cells Inhibits Colorectal Carcinogenesis Induced by Colibactin-Producing Escherichia coli in ApcMin/+ Mice.
10/2018	Colibactin: More Than a New Bacterial Toxin.
3/2017	Interactions between microsatellite instability and human gut colonization by Escherichia coli in colorectal cancer.
3/2016	Escherichia coli ClbS is a colibactin resistance protein.
2/2016	Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria.
12/2014	Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard Bonnet Research Topics

Disease

16	Infections 04/2024 - 05/2003
8	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 02/2016
7	Inflammation (Inflammations) 01/2023 - 12/2014
7	Crohn Disease (Crohn's Disease) 03/2021 - 04/2010
4	Carcinogenesis 01/2023 - 12/2014
3	Neoplasms (Cancer) 01/2024 - 12/2012
3	Colonic Neoplasms (Colon Cancer) 01/2024 - 01/2013
3	Meningitis 11/2010 - 06/2010
2	Genomic Instability 01/2024 - 03/2017
2	Dysbiosis 01/2021 - 01/2016
2	Bacteremia 11/2010 - 06/2010
1	Colitis 01/2021
1	Chromosomal Instability (Chromosome Stability) 10/2018
1	Cross Infection (Nosocomial Infection) 01/2018
1	Microsatellite Instability 03/2017
1	Fungal Meningitis 01/2017
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2013
1	Leukemia 11/2010
1	Abscess 08/2008
1	Osteomyelitis 06/2007
1	Staphylococcal Infections 03/2007
1	Malaria 03/2007
1	Renal Insufficiency (Renal Failure) 02/2007
1	Urinary Tract Infections (Urinary Tract Infection) 02/2007
1	Wound Infection (Wound Infections) 05/2003

Drug/Important Bio-Agent (IBA)

12	colibactinIBA 01/2024 - 12/2012
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2010
5	MutagensIBA 03/2017 - 12/2012
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 06/2007
2	LipidsIBA 01/2024 - 01/2019
2	Calcibiotic Root Canal SealerIBA 01/2024 - 02/2016
2	Volatile Fatty AcidsIBA 01/2021 - 01/2019
2	16S Ribosomal RNAIBA 01/2018 - 08/2008
2	Virulence Factors (Pathogenicity Factors)IBA 01/2016 - 09/2010
2	InterleukinsIBA 12/2014 - 06/2010
1	Cephalosporins (Cephalosporin Antibiotics)IBA 04/2024
1	Coenzyme A Ligases (Acid-Thiol Ligases)IBA 01/2024
1	Glycerophospholipids (Phosphoglycerides)IBA 01/2024
1	EnzymesIBA 01/2024
1	DNA (Deoxyribonucleic Acid)IBA 01/2024
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2024
1	cytotoxic necrotizing factor type 1IBA 01/2023
1	CytokinesIBA 01/2023
1	SiderophoresIBA 03/2021
1	yersiniabactinIBA 03/2021
1	Citric Acid (Citrate)FDA LinkGeneric 01/2021
1	PropionatesIBA 01/2021
1	Peroxidase (Myeloperoxidase)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	ChemokinesIBA 01/2019
1	lipopolysaccharide-binding proteinIBA 01/2019
1	Polymyxins (Polymyxin)IBA 12/2018
1	LipopolysaccharidesIBA 01/2018
1	Lipocalin-2IBA 01/2018
1	carbapenemaseIBA 01/2018
1	Colistin (Coly-Mycin)FDA Link 01/2017
1	Peptide Hydrolases (Proteases)FDA Link 05/2016
1	IntegrinsIBA 11/2015
1	GlycoconjugatesIBA 11/2015
1	AntibodiesIBA 11/2015
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2015
1	AzoxymethaneIBA 12/2014
1	Proto-Oncogene Proteins c-metIBA 12/2014
1	Dextrans (Dextran)FDA Link 12/2014
1	SodiumIBA 12/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2014
1	SugarsIBA 01/2014
1	Bile Acids and Salts (Bile Acids)IBA 02/2013
1	Amino Acids FDA Link 01/2013
1	Peptides (Polypeptides)IBA 12/2012
1	Cefotaxime (Kendrick)FDA LinkGeneric 10/2012
1	Interleukin-10 (Interleukin 10)IBA 06/2010
1	Messenger RNA (mRNA)IBA 04/2010
1	Histones (Histone)IBA 04/2010
1	Panton-Valentine leukocidinIBA 03/2007
1	Methicillin (Metin)FDA Link 03/2007
1	Doxycycline (Periostat)FDA LinkGeneric 03/2007
1	beta-Lactamases (beta-Lactamase)IBA 05/2003

Therapy/Procedure

2	Therapeutics 01/2018 - 05/2003
1	Drug Therapy (Chemotherapy) 01/2024
1	Rectal Administration 01/2023
1	Transplantation 01/2016
1	Hematopoietic Stem Cell Transplantation 11/2010
1	Surgical Amputation (Amputations) 06/2007
1	Urinary Catheters 02/2007
1	Free Tissue Flaps 05/2003